The Journal of Urology
Volume 166, Issue 2 , Pages 494-499 , August 2001

LONG-TERM TREATMENT RELATED COMPLICATIONS OF BRACHYTHERAPY FOR EARLY PROSTATE CANCER: A SURVEY OF PATIENTS PREVIOUSLY TREATED

,Accepted 2 February 2001.

REFERENCES 

  1. Fowler F , Barry MJ , Lu-Yao G , et al.   Patient-reported complications and followup treatment after radical prostatectomy: the National Medicare Experience: 1988–1990 (updated June 1993) . Urology . 1993;42:622
  2. Litwin MS , Hays RD , Fink A , et al.   Quality-of-life outcomes in men treated for localized prostate cancer . JAMA . 1995;273:129
  3. Beard CJ , Propert KJ , Rieker PP , et al.   Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study . J Clin Oncol . 1997;15:223
  4. Talcott JA , Rieker P , Propert KJ , et al.   Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy . J Natl Cancer Inst . 1997;89:1117
  5. Talcott JA , Rieker P , Clark JA , et al.   Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study . J Clin Oncol . 1998;16:275
  6. Stanford JL , Feng Z , Hamilton AS , et al.   Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study . JAMA . 2000;283:354
  7. Potosky AL , Miller BA , Albertsen PC , et al.   The role of increasing detection in the rising incidence of prostate cancer . JAMA . 1995;273:548
  8. Gann PH , Hennekens CH , Stampfer MJ . A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer . JAMA . 1995;273:289
  9. Whitmore WF , Hilaris B , Grabstald H . Retropubic implantation to iodine 125 in the treatment of prostatic cancer . J Urol . 1972;108:918
  10. Carlton CE , Dawoud F , Hudgins P , et al.   Irradiation treatment of carcinoma of the prostate: a preliminary report based on 8 years of experience . J Urol . 1972;108:924
  11. Kuban DA , el-Mahdi AM , Schellhammer PF . I-125 interstitial implantation for prostate cancer: what have we learned 10 years later? . Cancer . 1989;63:2415
  12. Gottesman JE , Tesh DG , Weissman WD . Failure of open radioactive 125iodine implantation to control localized prostate cancer: a study of 41 patients . J Urol . 1991;146:1317
  13. D’ Amico AV , Coleman CN . Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out . J Clin Oncol . 1996;14:304
  14. Blasko JC , Lange PH . Prostate cancer: the therapeutic challenge of locally advanced disease . N Engl J Med . 1997;337:340
  15. Blasko JC , Grimm PD , Ragde H . Brachytherapy and organ preservation in the management of carcinoma of the prostate . Semin Radiat Oncol . 1993;3:240
  16. Dattoli M , Wallner K , Sorace R , et al.   103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma . Int J Radiat Oncol Biol Phys . 1996;35:875
  17. Stock RG , Stone NN , De Wyngaert JK , et al.   Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma . Cancer . 1996;77:2386
  18. Nag S , Scaperoth DD , Badalament R , et al.   Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration . Urology . 1995;45:87
  19. Wallner K , Roy J , Harrison L . Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma . J Clin Oncol . 1996;14:449
  20. Zelefsky MJ , Wallner KE , Ling CC , et al.   Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer . J Clin Oncol . 1999;17:517
  21. Critz FA , Tarlton RS , Holladay DA . Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer—I-125 implant followed by external-beam radiation . Cancer . 1995;75:2383
  22. Talcott JA , Rieker P , Propert K , et al.   Long-term complications of treatment for early prostate cancer: 2-year followup in a prospective, multi-institutional outcomes study . Proc Annu Meet Am Soc Clin Oncol . 1996;5:252
  23. Fowler FJ , Barry MJ , Lu-Yao G , et al.   Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas . J Clin Oncol . 1996;14:2258
  24. Ragde H , Blasko JC , Grimm PD , et al.   Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma . Cancer . 1997;80:442
  25. Ragde H , Elgamal AA , Snow PB , et al.   Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma . Cancer . 1998;83:989
  26. Talcott JA , Jiroutek M , Rieker P , et al.   Complications of treatment for early prostate cancer: a prospective, multi-institutional outcomes validation study . Proc Annu Meet Am Soc Clin Oncol . 1997;16:A175
  27. Ragde H . Brachytherapy (seed implantation) for clinically localized prostate cancer . J Surg Oncol . 1997;64:79
  28. Sylvester J , Blasko JC , Grimm P , et al.   Interstitial implantation techniques in prostate cancer . J Surg Oncol . 1997;66:65
  29. Blasko JC , Ragde H , Grimm PD . Transperineal ultrasound-guided implantation of the prostate: morbidity and complications . Scand J Urol Nephrol . 1991;137(Suppl):113
  30. Feldman HA , Goldstein I , Hatzichristou DG , et al.   Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study . J Urol . 1994;151:54
  31. Hu K , Wallner K . Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy . Int J Radiat Oncol Biol Phys . 1998;40:783
  32. Green N , Treible D , Wallack H . Prostate cancer: post-irradiation incontinence . J Urol . 1990;144:307
  33. Lu-Yao GL , Barry MJ , Chang CH , et al.   Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes—Prostate Patient Outcomes Research Team (PORT) . Urology . 1994;44:692
  34. Fowler FJ . Prostate conditions, treatment decisions, and patient preferences . J Am Geriatr Soc . 1995;43:1058
  35. Fowler FJ , Barry MJ , Lu-Yao G , et al.   Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey . Urology . 1995;45:1007
  36. Stock RG , Stone NN , Tabert A , et al.   A dose-response study for I-125 prostate implants . Int J Radiat Oncol Biol Phys . 1998;41:101
  37. Wallner K , Roy J , Harrison L . Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy . Int J Radiat Oncol Biol Phys . 1995;32:465
  38. Nath R , Anderson LL , Luxton G , et al.   Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine . Med Phys . 1995;22:209
  39. Bice WS , Prestidge BR , Prete JJ , et al.   Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I: American Association of Physicists in Medicine . Int J Radiat Oncol Biol Phys . 1998;40:1237
  40. D’ Amico AV , Davis A , Vargas SO , et al.   Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated? . Int J Radiat Oncol Biol Phys . 1999;43:587
  41. D’ Amico AV , Cormack R , Tempany CM , et al.   Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer . Int J Radiat Oncol Biol Phys . 1998;42:507

 Editor’s Note:This article is the second of 5 published in this issue for which category 1 CME credits can be earn ed. Instructions for obtaining credits are given with the questions on pages 662 and 663.

PII: S0022-5347(05)65970-8

The Journal of Urology
Volume 166, Issue 2 , Pages 494-499 , August 2001